无论MAPK通路突变如何，MEK抑制剂对Erdheim-Chester病都有效

{"title":"无论MAPK通路突变如何，MEK抑制剂对Erdheim-Chester病都有效","authors":"Francesco Pegoraro, Fleur Cohen-Aubart, Matthias Papo, Francesco Catamerò, Jerome Razanamahery, Zahir Amoura, Jean-François Emile, Augusto Vaglio, Julien Haroche","doi":"10.1038/s41375-025-02614-6","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":18109,"journal":{"name":"Leukemia","volume":"17 1","pages":""},"PeriodicalIF":12.8000,"publicationDate":"2025-04-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"MEK inhibitors are effective in Erdheim–Chester disease regardless of MAPK pathway mutations\",\"authors\":\"Francesco Pegoraro, Fleur Cohen-Aubart, Matthias Papo, Francesco Catamerò, Jerome Razanamahery, Zahir Amoura, Jean-François Emile, Augusto Vaglio, Julien Haroche\",\"doi\":\"10.1038/s41375-025-02614-6\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":18109,\"journal\":{\"name\":\"Leukemia\",\"volume\":\"17 1\",\"pages\":\"\"},\"PeriodicalIF\":12.8000,\"publicationDate\":\"2025-04-23\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Leukemia\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1038/s41375-025-02614-6\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"HEMATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Leukemia","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1038/s41375-025-02614-6","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"HEMATOLOGY","Score":null,"Total":0}